Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Cancer is swiftly becoming a major health issue in India, affecting both urban and rural populations due to various factors. Innovative treatments like immunotherapy, targeted therapy, and gene ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

February marks Cancer Prevention Awareness Month, and local doctors are stressing the importance of early detection and prevention for two cancers that impact women: cervical and ovarian cancer.

February marks Cancer Prevention Awareness Month, and local doctors are stressing the importance of early detection and prevention for two cancers that impact women: cervical and ovarian cancer.